Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  BioMarin Pharmaceutical Inc.    BMRN

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo BioMarin Pharmaceutical In
Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions

BioMarin Pharmaceutical, Inc. engages in the biopharmaceutical development and commercialization of innovative pharmaceuticals for serious diseases and medical conditions.

Its company's products include Naglazyme, Kuvan, Aldurazyme, Firdapse and VIMIZIM.

The company was founded on March 21, 1997 and is headquartered in Novato, CA.

Number of employees : 2 158 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Biopharmaceutical Development and Commercialization751.04100.1%889.90101.9% +18.49%
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
United States380.0450.7%444.0850.8% +16.85%
Europe139.9418.7%178.7520.5% +27.73%
Latin America118.5615.8%142.3116.3% +20.03%
Rest of World112.4915%124.7714.3% +10.91%
Managers
NameAgeSinceTitle
Jean-Jacques Bienaimé632005Chairman & Chief Executive Officer
Daniel K. Spiegelman, MBA582012Chief Financial Officer & Executive Vice President
Henry J. Fuchs, MD592009Chief Medical Officer & Executive Vice President
Eduardo E. Von Pervieux, MBA-2008Chief Information Officer & Vice President
Elaine J. Heron PhD, MBA692002Independent Non-Executive Director
Michael G. Grey702005Independent Non-Executive Director
Richard A. Meier572006Lead Independent Non-Executive Director
V. Bryan Lawlis Jr., PhD652007Independent Non-Executive Director
Alan J. Lewis, PhD712005Independent Non-Executive Director
Dennis Joseph Slamon MD, PhD682014Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 171,987,437 171,352,810 99.6% 0 0.0% 99.6%
Shareholders
NameEquities%
Capital Research & Management Co. (Global Investors) 19,643,043 11.4%
The Vanguard Group, Inc. 13,207,286 7.68%
Sands Capital Management LLC 9,380,802 5.45%
Jennison Associates LLC 9,254,206 5.38%
BlackRock Fund Advisors 8,661,674 5.04%
PRIMECAP Management Co. 7,885,948 4.59%
Fidelity Management & Research Co. 7,543,465 4.39%
Baker Bros. Advisors LP 4,806,483 2.79%
SSgA Funds Management, Inc. 3,743,112 2.18%
Temasek Holdings Pte Ltd. (Investment Management) 3,472,712 2.02%
Holdings
NameEquities%Valuation
Catalyst Pharmaceuticals Inc (CPRX) 6,666,6678.03%7,466,667 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Biopharmaceuticals
Advertisement
Sector Biopharmaceuticals
1st jan.Capitalization (M$)
BIOMARIN PHARMACEUTICA..8.49%15 457
BIOGEN INC10.56%62 397
CSL LIMITED19.78%42 143
ALEXION PHARMACEUTICAL..5.29%28 847
GRIFOLS SA11.81%14 075
3SBIO INC2.89%2 548
JIANGXI BOYA BIO-PHARM..--.--%2 247
ABCAM PLC11.21%2 155
PROMETIC LIFE SCIENCES..7.02%1 160
HUGEL INC--.--%1 080
BIOTEST AG16.07%748
ANIKA THERAPEUTICS INC0.04%716
PHARMA MAR SA9.04%697
ARGOS THERAPEUTICS INC-4.08%194
MEDIWOUND LTD35.39%136
VIVUS, INC.-5.22%114
VERICEL CORP1.67%97
CARDIOME PHARMA CORP-0.51%96
ALIMERA SCIENCES INC12.96%79
CO DON AG33.22%74
STEADYMED LTD23.08%64
Sector Biopharmaceuticals
BioMarin Pharmaceutical In : Connections
Ziarco Pharma Ltd.
Targazyme, Inc.
Ziarco Group Ltd.
Reneo Pharmaceuticals, Inc.
Sutro Biopharma, Inc.
Rincon Pharmaceuticals, Inc.
Zephyrus Biosciences, Inc.
Rapidscan Pharma Solutions, Inc.
Amplyx Pharmaceuticals, Inc.
Reform Biologics LLC
Cytochroma, Inc.
Batu Biologics, Inc.
Selventa, Inc.
DiaVacs, Inc.
Balance Therapeutics, Inc.
Cellastra, Inc.
Biothera, Inc.
Biotechnology Innovation Organization
A. M. Pappas & Associates LLC
Sosei Co. Ltd.
Translational Research In Oncology
Jonsson Comprehensive Cancer Center
Capella Therapeutics, Inc.
Itero Biopharmaceuticals LLC
University of California, Los Angeles
AbSci LLC
David Geffen School of Medicine
Company contact information
770 street Lindaro
CA 94901 San Rafael, California
États-Unis (les)

Phone : +1 415 506 6700
Fax : +1 415 382 7889
Internet : http://www.bmrn.com
Markets and indexes
- NASDAQ All Markets
- Nasdaq Global Select Market
- Nasdaq 100 /
Stock Exchange Codes
- ISIN Code :  US09061G1013
- Bloomberg Code :  
- Reuters Code :  BMRN.O
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem